HRA/NRES

Health Research Authority (HRA) — Research Ethics Service

The HRA protects and promotes the interests of patients and the public in health and social care research.

National Ethics BoardLondon, United KingdomEst. 2011Website

Review capabilities & services

Study types reviewed

Phase IPhase IIPhase IIIPhase IVMedical devicesBiologicsVaccinesRare diseasePediatricOncologyObservational

Review services

Protocol reviewInformed consent reviewRecruitment material reviewAmendment reviewContinuing reviewSafety report reviewFull board review

Therapeutic-area experience

OncologyNeurologyRare diseasesInfectious diseasesCardiovascularImmunologyCell & gene therapyPediatricsVaccines

Review turnaround

Illustrative target turnaround by review type — confirm in your service agreement.

Initial protocol — full board30 d

Full board

Statutory ~30-day national REC opinion.

Amendment review20 d

Full board

Expedited / proportionate review14 d

Expedited

HRA/NRES

Health Research Authority (HRA) — Research Ethics Service

National Ethics Board · United Kingdom

Live record · illustrative seed data · scores deterministic, rules-based — not AI.